Home / ONCO.ST : STO

AI Analysis Fundamentals Valuation Earnings Video Analysis News Similar

AI Analysis

How does ONCO.ST make money? Does ONCO.ST have pricing power? What's the Earnings Whisper? Will ONCO.ST profit more as the business scales? What is ONCO.ST's management track record? Is ONCO.ST's current price justified?

Oncopeptides AB (publ)

SEK 1.67 -$3.21 (-65.72%)

STO · 30 Oct 2026 11:59 UTC

Previous Close

SEK 1.71

Day Range

SEK 1.67SEK 1.74

Year Range

SEK 1.25SEK 6.14

Market Cap

638.01M

AVG Volume

4.11M

Trailing/Forward PE

-2.14/-

PEG ratio

0.04

Dividend Yield

Next Earnings Date

2026-11-05

Primary Exchange

Stockholm Stock Exchange

Revenue (SEK) · A

ONCO.ST Revenue (SEK) by year
Period	Revenue (SEK)
2025	71.23M
2024	31.65M
2023	35.22M
2022	8.36M
2021	118.3M
2020	0
2019	0
2018	0
2017	0
2016	0

Net Income (SEK) · A

ONCO.ST Net Income (SEK) by year
Period	Net Income (SEK)
2025	-249.59M
2024	-284.61M
2023	-249.11M
2022	-337.95M
2021	-1.43B
2020	-1.59B
2019	-728.83M
2018	-419.45M
2017	-247.62M
2016	-114.45M

Operating Income (SEK) · A

ONCO.ST Operating Income (SEK) by year
Period	Operating Income (SEK)
2025	-225.5M
2024	-286.97M
2023	-251.61M
2022	-348.82M
2021	-1.42B
2020	-1.59B
2019	-727.51M
2018	-425.72M
2017	-247.62M
2016	-114.48M

EBITDA · A

Cash Flows · A

EPS · A

Expenses · A

Cash & Debt · A

Debt ratios · A

Margins · A

Return on Capital · A

Shares Outstanding · A

Dividends (SEK) · A

Employee Count

Book Value Per Share · A

Total Assets · A

PE Ratio

Free Cash Flow Yield

Price to Sales

EV/EBITDA

Price/Operating Cashflow

Price to Book

Estimate against actual revenue and earnings per share, the beat and miss record of recent reports, and how the price moved around each one. Next report: 5 Nov 2026.

No video analysis for this stock yet. Request one from our team.

AI Analysis

Oncopeptides AB (publ)

Earnings: ONCO.ST

Video analysis: ONCO.ST

News: ONCO.ST

Similar companies